Through proteolytic degradation of basement membranes and interstitial ECM components, MMP-9 releases matrix-sequestered growth factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), thereby amplifying local proangiogenic signaling and sustaining tumor vascularization and progression [13]. The gene discussed is MMP9; the disease is neoplasm.